Peter Ellis

Senior Lecturer in Molecular Genetics and Reproduction

University of Kent
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

The standard method for identification of male fertility status is a semen analysis. This is performed in fertility and pathology laboratories accredited by different bodies in the UK such as the HFEA or UKAS, and is based on whether they perform licenced clinical treatment or diagnostic testing. The WHO laboratory semen analysis criteria provide the most comprehensive guidance for best practice, yet this is not strictly adhered to. Our objective was to determine any differences in semen analyses between laboratories in the UK, based on the regulatory body they are registered with. A cross-sectional survey was sent to NEQAS for andrology registrants (n = 184 laboratories), HFEA (n = 117 clinics), and individual ARCS members (n = 682). Most ARCS members are associated with NEQAS and/or the HFEA. A ∼50% laboratory response rate (n = 106 included responses) was found. Results were grouped based on accreditation: Group 1, UKAS accredited only (n = 38); Group 2, both UKAS accredited and HFEA licenced (n = 17); Group 3, HFEA licenced only (n = 42); and Group 4, no accreditation (n = 9). Over 85% of UKAS accredited laboratories (Groups 1 and 2) state they perform semen analysis according to WHO 2010 recommendations and adhere to best practice guidelines. A significantly fewer number of HFEA only laboratories (<74% Group 3, p < 0.01 ) adhere to both guidelines. Non-HFEA laboratories (Groups 1 and 4) are almost all performing sperm counts according to WHO criteria, while <60% HFEA clinics (Groups 2 and 3) perform counts according to regulation (Group 1 vs. Groups 2 and 3: Fixed sperm, p < 0.05 ; Neubauer chamber: p < 0.005 ). QC is implemented in most laboratories, however there is a significant difference ( p < 0.01 ) between non-UKAS (Groups 3 and 4) and UKAS laboratories (Groups 1 and 2). There is a significant difference in semen analysis performance between UKAS and HFEA laboratories with regards to implementation of best practice guidelines and QC procedures. This may have a detrimental effect on result accuracy and consequently lead to patient misdiagnosis and mismanagement.

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (14)

Christopher Toseland

Senior Lecturer

University of Sheffield

UNITED KINGDOM
View details

Ben Skinner

Lecturer

University of Essex

UNITED KINGDOM
View details

Valdone Maciulyte

The Francis Crick Institute

UNITED KINGDOM
View details

Katie Harvey

Open University

UNITED KINGDOM
View details

Erica Larson

Assistant Professor

University of Denver

UNITED STATES
View details

Sheryl T Homa

University of Kent

UNITED KINGDOM
View details

Tarang Kumar Mehta

Lecturer in Bioinformatics

University of Liverpool

UNITED KINGDOM
View details

Natalia Fili

Senior Lecturer in Biomedical Biochemistry

University of Lincoln

UNITED KINGDOM
View details

Simon Harvey

Associate Dean - Research and Knowledge Exchange

University of Greenwich

UNITED KINGDOM
View details

Jeffrey M. Good

Associate Professor

University of Montana

UNITED STATES
View details

Roberta BERGERO

University of Edinburgh

UNITED KINGDOM
View details

Emily Kopania

University of Pittsburgh

UNITED STATES
View details

Marta Farré

Senior Lecturer in Genomics

University of Kent

UNITED KINGDOM
View details

Christian Simon Ottolini

Head of Embryology

Junia

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.